55 related articles for article (PubMed ID: 27455888)
1. Outcome of a drug-eluting stent in longer below-the-knee lesions in patients with critical limb ischemia.
Bosiers MJ; Deloose K; Peeters P; Torsello G; Zeller T; Scheinert D; Schmidt A; Maene L; Keirse K; Varcoe R; Bosiers M
J Cardiovasc Surg (Torino); 2017 Feb; 58(1):49-54. PubMed ID: 27455888
[TBL] [Abstract][Full Text] [Related]
2. Drug-Eluting Resorbable Scaffold versus Angioplasty for Infrapopliteal Artery Disease.
Varcoe RL; DeRubertis BG; Kolluri R; Krishnan P; Metzger DC; Bonaca MP; Shishehbor MH; Holden AH; Bajakian DR; Garcia LA; Kum SWC; Rundback J; Armstrong E; Lee JK; Khatib Y; Weinberg I; Garcia-Garcia HM; Ruster K; Teraphongphom NT; Zheng Y; Wang J; Jones-McMeans JM; Parikh SA;
N Engl J Med; 2024 Jan; 390(1):9-19. PubMed ID: 37888915
[TBL] [Abstract][Full Text] [Related]
3. Clinical Implications of Diabetic Peripheral Neuropathy in Primary Infrapopliteal Angioplasty Approach for Neuro-Ischemic Foot Wounds.
Alexandrescu VA; Van Overmeire L; Makrygiannis G; Azdad K; Popitiu M; Paquet S; Poppe L; Nodit M
J Endovasc Ther; 2023 Dec; 30(6):920-930. PubMed ID: 35786131
[TBL] [Abstract][Full Text] [Related]
4. Current Status of and Future Prospects for Drug-Eluting Stents and Scaffolds in Infrapopliteal Arteries.
Lim E; Varcoe RL
J Clin Med; 2024 Mar; 13(6):. PubMed ID: 38541981
[No Abstract] [Full Text] [Related]
5. A Single-Center Experience on Below-The-Knee Endovascular Treatment in Diabetic Patients.
Dinoto E; Pecoraro F; Mirabella D; Ferlito F; Farina A; Lo Biundo N; Orlando-Conti P; Bajardi G
Transl Med UniSa; 2020; 21():21-23. PubMed ID: 32123676
[TBL] [Abstract][Full Text] [Related]
6. Absorbable Drug Eluting Stents May Bring LIFE to the Treatment of Below the Knee Lesions in Peripheral Arterial Disease.
Nordanstig J; Mani K
Eur J Vasc Endovasc Surg; 2024 May; ():. PubMed ID: 38762042
[No Abstract] [Full Text] [Related]
7. Diabetes does not worsen outcomes following infrageniculate bypass or endovascular intervention for patients with critical limb ischemia.
Hicks CW; Najafian A; Farber A; Menard MT; Malas MB; Black JH; Abularrage CJ
J Vasc Surg; 2016 Dec; 64(6):1667-1674.e1. PubMed ID: 27871493
[TBL] [Abstract][Full Text] [Related]
8. Everolimus-Eluting Stent for Patients With Critical Limb Ischemia and Infrapopliteal Arterial Occlusive Disease.
Giaquinta A; Vincenzo A; De Marco E; Veroux M; Veroux P
Vasc Endovascular Surg; 2017 Feb; 51(2):60-66. PubMed ID: 28100126
[TBL] [Abstract][Full Text] [Related]
9. One-Year Outcomes of the Paclitaxel-Eluting, Self-Expanding Stentys Stent System in the Treatment of Infrapopliteal Lesions in Patients With Critical Limb Ischemia.
Bosiers M; Callaert J; Keirse K; Hendriks JMH; Peeters P; Verbist J; Maene L; Beelen R; Deloose K
J Endovasc Ther; 2017 Jun; 24(3):311-316. PubMed ID: 28351310
[TBL] [Abstract][Full Text] [Related]
10. The effect of ambulatory status on outcomes of percutaneous vascular interventions and lower extremity bypass for critical limb ischemia in the Vascular Quality Initiative.
Lu K; Farber A; Schermerhorn ML; Patel VI; Kalish JA; Rybin D; Doros G; Siracuse JJ
J Vasc Surg; 2017 Jun; 65(6):1706-1712. PubMed ID: 28216361
[TBL] [Abstract][Full Text] [Related]
11. Results of common femoral artery thromboendarterectomy evaluation of a traditional surgical management in the endovascular era.
Wieker CM; Schönefeld E; Osada N; Lührs C; Beneking R; Torsello G; Böckler D
J Vasc Surg; 2016 Oct; 64(4):995-1001. PubMed ID: 27666444
[TBL] [Abstract][Full Text] [Related]
12. Reduced high-density lipoprotein cholesterol: A valuable, independent prognostic marker in peripheral arterial disease.
Martinez-Aguilar E; Orbe J; Fernández-Montero A; Fernández-Alonso S; Rodríguez JA; Fernández-Alonso L; Páramo JA; Roncal C
J Vasc Surg; 2017 Nov; 66(5):1527-1533.e1. PubMed ID: 28666822
[TBL] [Abstract][Full Text] [Related]
13. Regional variation in outcomes for lower extremity vascular disease in the Vascular Quality Initiative.
Soden PA; Zettervall SL; Shean KE; Vouyouka AG; Goodney PP; Mills JL; Hallett JW; Schermerhorn ML;
J Vasc Surg; 2017 Sep; 66(3):810-818. PubMed ID: 28450103
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Comparative Outcomes of Patients With Peripheral Artery Disease With and Without Concomitant Coronary Artery Disease.
Chen DC; Singh GD; Armstrong EJ; Waldo SW; Laird JR; Amsterdam EA
Am J Cardiol; 2017 Apr; 119(8):1146-1152. PubMed ID: 28259239
[TBL] [Abstract][Full Text] [Related]
15. Perioperative outcomes of infrainguinal bypass surgery in patients with and without prior revascularization.
Bodewes TCF; Ultee KHJ; Soden PA; Zettervall SL; Shean KE; Jones DW; Moll FL; Schermerhorn ML
J Vasc Surg; 2017 May; 65(5):1354-1365.e2. PubMed ID: 28190717
[TBL] [Abstract][Full Text] [Related]
16. Risk Factors for 30-Day Hospital Re-Admission with an Infectious Complication after Lower-Extremity Vascular Procedures.
Melvin JC; Smith JB; Kruse RL; Vogel TR
Surg Infect (Larchmt); 2017 Apr; 18(3):319-326. PubMed ID: 28177854
[TBL] [Abstract][Full Text] [Related]
17. The IN.PACT DEEP Clinical Drug-Coated Balloon Trial: 5-Year Outcomes.
Zeller T; Micari A; Scheinert D; Baumgartner I; Bosiers M; Vermassen FEG; Banyai M; Shishehbor MH; Wang H; Brodmann M;
JACC Cardiovasc Interv; 2020 Feb; 13(4):431-443. PubMed ID: 32081236
[TBL] [Abstract][Full Text] [Related]
18. A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trial.
Gray WA; Keirse K; Soga Y; Benko A; Babaev A; Yokoi Y; Schroeder H; Prem JT; Holden A; Popma J; Jaff MR; Diaz-Cartelle J; Müller-Hülsbeck S;
Lancet; 2018 Oct; 392(10157):1541-1551. PubMed ID: 30262332
[TBL] [Abstract][Full Text] [Related]
19. Safety of Paclitaxel-Coated Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease.
Ouriel K; Adelman MA; Rosenfield K; Scheinert D; Brodmann M; Peña C; Geraghty P; Lee A; White R; Clair DG
JACC Cardiovasc Interv; 2019 Dec; 12(24):2515-2524. PubMed ID: 31575518
[TBL] [Abstract][Full Text] [Related]
20. Randomized Controlled Trial of Acotec Drug-Eluting Balloon Versus Plain Balloon for Below-the-Knee Angioplasty.
Liistro F; Angioli P; Ventoruzzo G; Ducci K; Reccia MR; Ricci L; Falsini G; Scatena A; Pieroni M; Bolognese L
JACC Cardiovasc Interv; 2020 Oct; 13(19):2277-2286. PubMed ID: 32950416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
